Our Stocks to Watch tomorrow include Emergent Health Corp. (OTC: EMGE), Legend Media Inc. (OTCBB: LEGE), Power3 Medical Products Inc. (OTCBB: PWRM), Trey Resources Inc. (OTCBB: TYRIA), American Scientific Resources Inc. (OTC: ASFX) and Discovery Laboratories Inc. (Nasdaq: DSCO).
EMERGENT HEALTH CORPORATION (OTC: EMGE)
"Up 113.51% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/EMGE.php
Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.
EMGE News:
October 30 - Emergent Health Corp. Confirms Stock Split
Emergent Health Corp. (OTC: EMGE) (the “Company”) announces a forward stock split of 11 shares for each 10 shares owned. All fractional shares will be rounded off to the next whole number. The stock split will be to all stockholders of record as of December 31, 2009.
To receive the new shares, all shareholders must submit their current certificate with a check for $15 for issuance of a certificate for the new shares, to Olde Monmouth Stock Transfer Co., Inc. located at
This action, when in effect, will result in a symbol change for the Company as well as a new CUSIP Number.
The Company remains solvent and continues to be committed to its long-term business objectives.
LEGEND MEDIA INCORPORATED (OTCBB: LEGE)
"Up 81.82% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/LEGE.php
Legend Media (OTCBB: LEGE) is a leading advertising firm in focused on
LEGE News:
September 21 - Legend Media, Inc. Announces Expansion of Xinhua Airline Magazine's Potential Audience as
Legend Media, Inc. (OTCBB: LEGE), a leading China advertising company focused on selling ad space in airline magazines and major radio markets, announced that Hainan Airlines has added three new nonstop routes to their offerings beginning this month. Legend Media, Inc. owns an exclusive sales contract for Xinhua Airline Magazine, the in-flight publication for Hainan Airline ("HNA") Group, which reaches a potential audience of more than 20 million passengers per year and keeps growing as the airline expands operations.
In September 2009, Hainan Airlines added nonstop routes from
Hainan Airlines passenger ridership rose 13.2% to 8.1 million in the first half of 2009 compared to the same period in 2008, coinciding with the strong domestic recovery. HNA expects to improve its performance in the second half as "stable growth of the domestic market, lower fuel prices and gradual implementation of the government's favorable policies" take effect. It said the "international market has showed signs of hitting the bottom."
George Soros, chairman of Soros Fund Management, has invested $50 million USD into various airline holdings of HNA Group.
Legend Media entered into the exclusive contract with Xinhua Airline Magazine in late 2008 and has since seen its ability to target
POWER 3 MEDICAL PRODUCTS INCORPORATED (OTCBB: PWRM)
"Up 50.48% on Friday"
Detailed Quote: www.otcpicks.com/quotes/PWRM.php
Power3 Medical Products Inc. is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston),
PWRM News:
September 18 - Emerging Stock Report Initiates Independent Research Coverage On Power3 Medical Products, Inc.
Emerging Stock Report, a leading provider of sector specific independent investment research, initiated coverage on Power3 Medical Products, Inc. (OTCBB: PWRM). Emerging Stock Report is currently offering a complimentary trial subscription. To view the company's research go to http://www.emergingstockreport.com.
TREY RESOURCES INCORPORATED (OTCBB: TYRIA)
"Up 50.00% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/TYRIA.php
Trey Resources is involved in the acquisition and build-out of technology and software companies. The Company's growth strategy is to acquire firms in this extensive and expanding, but highly fragmented segment, as it seeks to create substantial value for shareholders. Since June 2004, Trey has acquired SWK Technologies, Inc., Business Tech Solutions Group, Inc., Wolen Katz Associates, and AMP-BEST Consulting, Inc.
TYRIA News:
September 10 - Trey Resources Releases Quarterly Income Statement
Visit http://bit.ly/MTS8d to view the income statement for Trey Resources Inc. (OTCBB: TYRIA) for the quater ended June 30, 2009.
AMERICAN SCIENTIFIC RESOURCES INCORPORATED (OTC: ASFX)
"Up 17.95% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/ASFX.php
American Scientific Resources, Inc. is the parent company for wholly-owned subsidiaries, Kidz-Med and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market.
ASFX News:
October 22 - American Scientific Resources Announces Addition of New Board Member
American Scientific Resources, Inc. (OTC: ASFX) announced the addition of a new member to the Company's board of directors: Mr. Jason Roth, the Company's newly appointed Senior Vice-President and Director of Business Development.
Mr. Roth, a successful entrepreneur & marketing specialist in the medical supply industry, has taken great strides to advance the Company's brand and provide for an additional revenue channel by introducing the world's only FDA approved home needle destruction device, the Disintegrator Plus(TM), to ASR who acquired the exclusive selling and intellectual property rights from Safeguard Medical Technologies LLC.
Dr. Christopher F. Tirotta, CEO for American Scientific commented, "We are pleased to welcome Jason to the Board and look forward to seeing the results derived from his contacts and expertise."
DISCOVERY LABS INCORPORATED (NASDAQ: DSCO)
"Up 17.72% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/DSCO.php
Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs' novel proprietary KL4 Surfactant Technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations. In addition, Discovery Labs' proprietary Capillary Aerosolization Technology produces a dense aerosol, with a defined particle size that is capable of potentially delivering aerosolized KL4 surfactant to the deep lung without the complications currently associated with liquid surfactant administration. Discovery Labs is focused initially on developing its KL4 surfactant pipeline to build a pediatric franchise that will potentially address several respiratory conditions affecting neonates and young children, beginning with Respiratory Distress Syndrome (RDS).
DSCO News:
October 27 - Trading Review for Discovery Laboratories Inc. Issued by Beacon Equity
BeaconEquity.com announces an investment report featuring biotechnology company Discovery Laboratories Inc. (Nasdaq: DSCO). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The investment report on Discovery Laboratories Inc. (Nasdaq: DSCO) should be of particular interest to biotechnology companies: Abbott Laboratories (NYSE: ABT), Forest Laboratories Inc. (NYSE: FRX) and Life Technologies (Nasdaq: LIFE).
It is available at www.beaconequity.com/i/DSCO.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.